NEA 14 GP, LTD

10% owner at INTERLOTT TECHNOLOGIES INC · on record since May 23, 2013
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at Tracon Pharmaceuticals, Inc. · on record since Jan 29, 2015
10% owner at CHAMPIONS ONCOLOGY, INC. · on record since Mar 24, 2015
10% owner at SYNLOGIC, INC. · on record since Sep 30, 2015
10% owner at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
10% owner at MULESOFT, INC · on record since Mar 22, 2017
10% owner at APPIAN CORP · on record since May 31, 2017
10% owner at Mersana Therapeutics, Inc. · on record since Jun 27, 2017
10% owner at Strongbridge Biopharma plc · on record since Jan 9, 2018
Director at SYNLOGIC, INC. · on record since Aug 14, 2026
10% owner at Surface Oncology, Inc. · on record since Apr 18, 2018
10% owner at Oyster Point Pharma, Inc. · on record since Oct 30, 2019
10% owner at Galera Therapeutics, Inc. · on record since Nov 12, 2019
10% owner at 11 GOOD ENERGY INC · on record since Mar 16, 2020
10% owner at Casper Sleep Inc. · on record since Feb 12, 2020
10% owner at ZeroFox Holdings, Inc. · on record since Aug 5, 2022
10% owner at Avalo Therapeutics, Inc. · on record since Oct 20, 2015

Insider trading activity of NEA 14 GP, LTD

Transactions on record: 29; since Oct 20, 2015

Open-market buys: 8; $35.3M

Open-market sells: 1; $5M

Companies traded: 7; last filing Apr 13, 2020

Figures computed from official regulatory filings — .

Companies where NEA 14 GP, LTD has traded

8 tx · $15M · Apr 13, 2020
3 tx · $9.9M · Mar 10, 2020
5 tx · $16.4M · Sep 10, 2018
4 tx · $4M · Mar 27, 2018
5 tx · Feb 15, 2018
2 tx · $4M · Jan 26, 2018
2 tx · Oct 20, 2015

Track record of NEA 14 GP, LTD

Statistical track record

Free account

Open-market buys: 10

Last buy: Sep 7, 2018

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of NEA 14 GP, LTD

Co-insiders of NEA 14 GP, LTD

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Mersana Therapeutics, Inc.Listing unverified	Apr 13, 2020	Other	-40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mersana Therapeutics, Inc.Listing unverified	Apr 13, 2020	Other	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mersana Therapeutics, Inc.Listing unverified	Apr 13, 2020	Other	-4,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Mar 10, 2020	Sell	-708,155	6.99 USD	$5M		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Mar 10, 2020	Other	859,375	5.76 USD	$5M		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Mar 10, 2020	OtherD (derivative)	-859,375	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Sep 10, 2018	Buy	3,000,000	1.67 USD	$5M	conv 34Cluster	SEC
Tracon Pharmaceuticals, Inc.Listing on record	Mar 27, 2018	Buy	707,964	2.70 USD	$1.9M	conv 40Cluster	SEC
Tracon Pharmaceuticals, Inc.Listing on record	Mar 27, 2018	Buy	707,964	2.70 USD	$1.9M	conv 40Cluster	SEC
Tracon Pharmaceuticals, Inc.Listing on record	Mar 27, 2018	BuyD (derivative)	707,964	0.13 USD	$92K	Cluster	SEC
Tracon Pharmaceuticals, Inc.Listing on record	Mar 27, 2018	BuyD (derivative)	707,964	0.13 USD	$92K	Cluster	SEC
Adaptimmune Therapeutics PLCListing unverified	Mar 23, 2018	Buy	869,574	1.90 USD	$1.7M	conv 25Cluster	SEC
Adaptimmune Therapeutics PLCListing unverified	Mar 23, 2018	Buy	294,090	1.95 USD	$573.5K	conv 25Cluster	SEC
Adaptimmune Therapeutics PLCListing unverified	Mar 23, 2018	Buy	104,844	1.81 USD	$189.8K	conv 34Cluster	SEC
APPIAN CORPListing on record	Feb 15, 2018	Other	-2,724,202	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPIAN CORPListing on record	Feb 15, 2018	OtherD (derivative)	-2,724,202	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPIAN CORPListing on record	Feb 15, 2018	Other	27,242	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPIAN CORPListing on record	Feb 15, 2018	Other	-27,242	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPIAN CORPListing on record	Feb 15, 2018	Other	2,724,202	—	n/a (No price was disclosed in the filing)		SEC
SYNLOGIC, INC.Listing on record	Jan 26, 2018	Award	410,000	9.75 USD	$4M		SEC
SYNLOGIC, INC.Listing on record	Aug 30, 2017	Award	3,394,439	—	n/a (No price was disclosed in the filing)		SEC
Mersana Therapeutics, Inc.Listing unverified	Jul 6, 2017	Buy	1,000,000	15.00 USD	$15M	conv 43Cluster	SEC
Mersana Therapeutics, Inc.Listing unverified	Jul 6, 2017	Other	7,140,138	—	n/a (No price was disclosed in the filing)		SEC
Mersana Therapeutics, Inc.Listing unverified	Jul 6, 2017	OtherD (derivative)	-11,931,173	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mersana Therapeutics, Inc.Listing unverified	Jul 6, 2017	OtherD (derivative)	-2,216,626	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Mersana Therapeutics, Inc.Listing unverified	Apr 13, 2020	Other	-40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mersana Therapeutics, Inc.Listing unverified	Apr 13, 2020	Other	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mersana Therapeutics, Inc.Listing unverified	Apr 13, 2020	Other	-4,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Mar 10, 2020	Sell	-708,155	6.99 USD	$5M		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Mar 10, 2020	Other	859,375	5.76 USD	$5M		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Mar 10, 2020	OtherD (derivative)	-859,375	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adaptimmune Therapeutics PLCListing unverified	Sep 10, 2018	Buy	3,000,000	1.67 USD	$5M	conv 34Cluster	SEC
Tracon Pharmaceuticals, Inc.Listing on record	Mar 27, 2018	Buy	707,964	2.70 USD	$1.9M	conv 40Cluster	SEC
Tracon Pharmaceuticals, Inc.Listing on record	Mar 27, 2018	Buy	707,964	2.70 USD	$1.9M	conv 40Cluster	SEC
Tracon Pharmaceuticals, Inc.Listing on record	Mar 27, 2018	BuyD (derivative)	707,964	0.13 USD	$92K	Cluster	SEC
Tracon Pharmaceuticals, Inc.Listing on record	Mar 27, 2018	BuyD (derivative)	707,964	0.13 USD	$92K	Cluster	SEC
Adaptimmune Therapeutics PLCListing unverified	Mar 23, 2018	Buy	869,574	1.90 USD	$1.7M	conv 25Cluster	SEC
Adaptimmune Therapeutics PLCListing unverified	Mar 23, 2018	Buy	294,090	1.95 USD	$573.5K	conv 25Cluster	SEC
Adaptimmune Therapeutics PLCListing unverified	Mar 23, 2018	Buy	104,844	1.81 USD	$189.8K	conv 34Cluster	SEC
APPIAN CORPListing on record	Feb 15, 2018	Other	-2,724,202	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPIAN CORPListing on record	Feb 15, 2018	OtherD (derivative)	-2,724,202	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPIAN CORPListing on record	Feb 15, 2018	Other	27,242	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPIAN CORPListing on record	Feb 15, 2018	Other	-27,242	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPIAN CORPListing on record	Feb 15, 2018	Other	2,724,202	—	n/a (No price was disclosed in the filing)		SEC
SYNLOGIC, INC.Listing on record	Jan 26, 2018	Award	410,000	9.75 USD	$4M		SEC
SYNLOGIC, INC.Listing on record	Aug 30, 2017	Award	3,394,439	—	n/a (No price was disclosed in the filing)		SEC
Mersana Therapeutics, Inc.Listing unverified	Jul 6, 2017	Buy	1,000,000	15.00 USD	$15M	conv 43Cluster	SEC
Mersana Therapeutics, Inc.Listing unverified	Jul 6, 2017	Other	7,140,138	—	n/a (No price was disclosed in the filing)		SEC
Mersana Therapeutics, Inc.Listing unverified	Jul 6, 2017	OtherD (derivative)	-11,931,173	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mersana Therapeutics, Inc.Listing unverified	Jul 6, 2017	OtherD (derivative)	-2,216,626	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC